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HIV infection is now considered as a chronic disease,
most patients being well-controlled and experiencing
long-term survival. However, these patients encounter
an increasing number of complications and in particular
of age-related comorbidities occurring earlier than in
the general population: cardiovascular disease, dyslipide-
mia, diabetes, osteoporosis, liver and kidney failure, neu-
rocognitive impairment, non-AIDS defining cancers.
Therefore, it is now considered than some patients pre-
sent a phenotype of premature aging, the origin of
which remains unknown.
In the general population, most age-related comorbid-
ities including cancer have been linked to long-term
chronic inflammation (inflammaging). This inflamma-
tion could partly result from adipose tissue redistribu-
tion and hypertrophy leading to insulin resistance,
dyslipidemia and altered glucose tolerance. Inflamma-
tion is also involved in the occurrence of atherosclerosis
and increased cardio-vascular risk, osteoporosis, liver
dysfunction and neurocognitive disorders. Two main
contributors to cellular senescence and inflammation
are activation of the monocyte/macrophage system and
increased oxidative stress.
In HIV-infected patients, recent works indicate that
even well-controlled patients present low-grade inflam-
mation as shown by increased level of CRP. Links
between CRP, increased intima-media thickness and the
occurrence of myocardial infarction have been shown.
Similarly, it is hypothesized than brain inflammation
could play a role in neurocognitive impairment pre-
sented by some patients. The origin of increased inflam-
mation is probably complex and multifactorial. A role
for persistent viral infection is postulated and infected
immune cells such as macrophages can produce deleter-
ious viral proteins, induce an oxidative stress and release
pro-inflammatory cytokines. Long-term immune activa-
tion could result in immunosenescence and increased
proinflammatory cytokines level. Some antiretroviral
drugs induce an oxidative stress. Finally, patients’ linked
parameters are important to consider: age, smoking,
metabolic disorders, hypertension, vitamin D deficiency
and life-style environment (lipid-rich diet, sedentarity).
It is important to control these alterations: treat early,
avoid drugs with specific tissue toxicity in patients with
risk factors, take in charge the metabolic alterations
(hypertension, dyslipidemia, diabetes), compensate vita-
min D deficiency if present. A safe life-style (stopping
smoking, exercise, diet) is strongly recommended for
these patients.
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